Paper

Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.

Published May 22, 2014 · K. Santos, M. Laranjo, A. Abrantes

European journal of medicinal chemistry

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles show potential as anticancer agents for triple-negative breast cancer, particularly in treating HCC1806 cells.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.

References

Citations